Home

Join us in the 6th Academic Medicine Advisory Council (AMAC) Meeting, from 15 - 17 April 2025, led by Professor Victor Dzau and a newly appointed AMAC panel, where fresh insights and strategic recommendations for the progress of our SingHealth Duke-NUS Academic Medical Centre (AMC) will be discussed, with the participation of the Academic Clinical Programmes (ACPs), Signature Research Programmes (SRPs), Joint Institutes (JIs), SingHealth Duke-NUS Disease Centres (SDDCs) and the broader AMC family.

Current challenges will be addressed through engaging dialogues and keynote lectures centering around three strategic themes:

Programme

We have an exciting programme line-up comprising AMAC 2025 Opening and Closing Meetings, themed dialogue sessions and Academic Hour with AMAC. Click to view our full programme!

Academic Hour with AMAC

Join us for an exceptional opportunity to hear from internationally renowned thought leaders who will share their invaluable perspectives and leadership insights on emerging topics, such as Population Health and the transformative power of artificial intelligence (AI) in Healthcare.

AMAC 2025 is back with an exciting programme to engage all healthcare professionals, faculty and staff across our SingHealth Duke-NUS Academic Medical Centre. Come meet the great minds in Academic Medicine and join in the sessions for the progress our AM journey!

NOTICEBOARD

Unlock cutting-edge insights at Academic Hour with AMAC, when leading minds in Academic Medicine share the application of
their groundbreaking research in clinical care to improve health.

Come listen to Prof Sheri Johnson on 15 April 2025 (Tuesday) from 11:15am - 12:15pm as she shares how social, economic, and
environmental factors shape health outcomes, while we explore how to adopt and apply the lessons learned from her US experience
in reducing health disparities in the Singapore setting.

Why personalised medicine? And how can AI help bring it to life?
Join Prof Russ Altman on 16 April 2025 (Wednesday) from 8:00am - 9:00pm as he reveals how PopDX, an AI tool

developed by his team, predicts disease risks using large health databases like the UK Biobank and the US All of Us project,

thus advancing personalised medicine and improving disease prevention.

NOTICEBOARD

Prof Ivy Ng

SingHealth GCEO